What type of cancer is Rubraca used to treat?
Rubraca (rucaparib) is used for the treatment of certain types of ovarian cancer and prostate cancer.
Rubraca belongs to the class of drugs called poly (ADP-ribose) polymerase (PARP) inhibitors which are targeted therapies used in the treatment of certain types of cancer.
Ovarian Cancer
Rubraca is used for the treatment of ovarian cancer, fallopian tube cancer, or primary peritoneal cancer in patients who have a germline (inherited) and/or somatic (acquired) abnormal BRCA gene, and who have been treated with two or more types of chemotherapy.
Rubraca is also used for the maintenance treatment of ovarian cancer, fallopian tube cancer, or primary peritoneal cancer that has returned in patients who have received platinum-based chemotherapy.
Prostate Cancer
Rubraca is used for the treatment of metastatic (has spread to other parts of the body) castration-resistant prostate cancer (prostate cancer that no longer responds to medical or surgical treatment that lowers testosterone) in patients that have a germline and/or somatic abnormal BRCA gene who have been treated with androgen receptor-directed therapy and a taxane-based chemotherapy.
Read next
Why has Xtandi stopped working and what do I take next?
Prostate cancer cells, like bacteria, can evolve over time and become resistant to treatments, including the hormone therapy and androgen receptor inhibitor Xtandi (enzalutamide). The cancer cells work to reprogram their environment and develop strategies that enable them to transform and survive.
If treatment with Xtandi stops working then other treatments may be offered, such as:
- Chemotherapy
- Immunotherapy
- Targeted therapy
- Radiotherapy
Stopping treatment with Xtandi may also result in an antiandrogen withdrawal response (AAWR), which can cause the cancer to stop growing or shrink for the period of time. Continue reading
How long does Xtandi work?
Xtandi is typically taken until prostate cancer starts to progress or spread (metastasize), or until the patient can no longer tolerate therapy because of the side effects or adverse events it causes.
In clinical trials, Xtandi was effective at delaying the time to disease progression in men with advanced prostate cancer. In men who had not received prior treatment with chemotherapy, Xtandi was also effective at delaying the need for treatment with a cytotoxic chemotherapy agent.
In the AFFIRM trial, treatment with Xtandi extended life by almost 5 months in men with metastatic castration-resistant prostate cancer. Continue reading
How long do you take Orgovyx for?
Orgovyx (relugolix) is taken once daily for as long as it remains effective and side effects are manageable. Prostate cancer often requires long-term hormone control, and studies show Orgovyx can be used safely for up to 48 weeks. Continue reading
Related medical questions
- What type of prostate cancer is Erleada used to treat?
- What medications can increase PSA levels?
- Why is prednisone prescribed with Zytiga?
- How long do you take Zytiga for?
- Xtandi vs Zytiga: How do they compare?
- What happens when you stop taking Casodex?
- How long should you take Eligard for?
- Are Lupron Depot and Eligard the same drug?
- Erleada vs. Xtandi: What's the difference?
- How long should you take Casodex for?
- Can you get pregnant on Lupron Depot?
- How long do you have to take Erleada (apalutamide) for?
- Does Xtandi lower prostate-specific antigen (PSA)?
- Is Zytiga a form of chemotherapy?
- Is Lupron Depot a chemotherapy treatment?
- How effective is Casodex for prostate cancer?
- How long does it take Lynparza (olaparib) to work?
- Is Firmagon (degarelix) the same as Lupron?
- How do you inject Lupron Depot for prostate cancer?
- How is Eligard injected / administered for prostate cancer?
- Is Eligard a chemotherapy drug?
- How effective is Lynparza (olaparib)?
- How effective is Erleada (apalutamide)?
- What does abiraterone therapy do?
- What is the mechanism of action for Erleada?
- How long does it take for Degarelix to work?
- What's the difference between Yonsa and Zytiga?
Drug information
Related support groups
- Rucaparib (1 questions, 3 members)
- Rubraca (1 questions, 4 members)
- Prostate Cancer (59 questions, 158 members)
- Ovarian Cancer (12 questions, 56 members)
- Fallopian Tube Cancer (3 questions, 4 members)
- Peritoneal Cancer (3 questions, 7 members)